# Release Notes — Version 1.0.0

**Release Date:** 30 June 2026

## Modernized Biomarker Discovery Framework — Version 1.0

This release marks the first stable public version of the **Modernized Biomarker Discovery Framework**, an object-oriented R framework for developing reproducible biomarker discovery pipelines in translational oncology.

Version 1.0 establishes the complete architectural foundation of the framework, including governance, methodology, implementation, package infrastructure, public documentation, and repository release engineering.

---

# Highlights

## Complete Framework Architecture

The repository now contains a fully integrated framework covering:

* Governance Framework
* Coding Framework
* Methodology Framework
* Repository Release Framework

All architectural components have been reviewed, integrated, and locked under Governance v4.6.

---

## Object-Oriented Framework Design

The framework introduces a modular implementation architecture based on:

* Workflow Objects
* Executor Objects
* Implementation Objects
* Framework Artifacts

This separation preserves clear responsibilities while enabling future extensibility without modifying the core architecture.

---

## Complete Discovery and Modeling Foundations

Version 1.0 includes implementation of the complete Coding Framework (Modules 01–15), covering:

* Repository foundation
* Framework contracts
* Discovery workflow
* Discovery execution
* Discovery output boundary
* Modeling construction
* Modeling management
* Modeling output boundary
* Validation architecture
* Interpretation architecture
* Clinical translation architecture

All modules are complete and governance locked.

---

## Public Documentation

Version 1.0 provides a complete public documentation set including:

* README
* Quick Start
* Installation Guide
* Framework Overview
* Architecture Overview
* Examples
* FAQ
* Citation Guide
* Contributing Guide

Documentation has been reviewed for consistency, navigation, and cross-link integrity.

---

## Reproducibility

Repository reproducibility has been validated through:

* dependency restoration
* package installation
* package loading
* canonical smoke test
* session information recording
* release evidence collection

Version 1.0 represents the validated reproducible baseline of the project.

---

## Repository Quality Assurance

Repository Quality Assurance includes:

* repository structure review
* documentation review
* navigation verification
* release asset verification
* package integrity validation
* reproducibility assessment

The repository has completed the complete WP1–WP6 release workflow.

---

# Repository Structure

The repository contains:

* R package source code
* Complete framework specifications
* Public documentation
* Execution history
* Reproducibility resources
* Release engineering documentation

---

# Intended Audience

Version 1.0 is intended for:

* Translational cancer researchers
* Bioinformatics researchers
* Computational oncology researchers
* R package developers
* Biomarker framework developers
* Reproducible research practitioners

---

# Compatibility

Validated with:

* R 4.4.x
* renv-managed environments
* roxygen2
* devtools
* testthat (3rd Edition)

---

# Citation

Please cite this repository using the provided `CITATION.cff` metadata or the guidance in `docs/CITATION.md`.

---

# Acknowledgements

This release represents the completion of the initial framework development phase and establishes the official Version 1.0 baseline for future development.

Future releases will extend the framework through additive functionality while preserving the locked architectural foundations established in Version 1.0.
